Skip to content
HowShorted

RIGEL PHARMACEUTICALS INC short interest in 2024

In 2024, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 1.96% of shares outstanding on 12 Jan 2024 to 4.58% on 31 Dec 2024, a change of +2.62 percentage points. The year's high was 4.58% on 31 Dec 2024 and its low 1.96% on 12 Jan 2024, averaging 2.97% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.85 days on 31 Oct 2024. Full history: RIGEL PHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for RIGEL PHARMACEUTICALS INC in 2024

2024 in figures

Start of year
1.96% (12 Jan 2024)
End of year
4.58% (31 Dec 2024)
Change
+2.62 pp
High
4.58% (31 Dec 2024)
Low
1.96% (12 Jan 2024)
Average
2.97%
Highest days to cover
6.85 (31 Oct 2024)
SEC filings marked
9

Every report in 2024

RIGEL PHARMACEUTICALS INC short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.96%3.76results (8-K)
31 Jan 20241.96%4.44
15 Feb 20242.01%3.98
29 Feb 20242.14%2.93
15 Mar 20242.84%2.7210-K filed, results (8-K)
28 Mar 20242.88%5.46
15 Apr 20242.96%2.47
30 Apr 20243.25%3.11
15 May 20243.22%5.2110-Q filed, results (8-K)
31 May 20243.01%4.96
14 Jun 20242.79%3.59
15 Aug 20243.21%4.5310-Q filed, results (8-K)
30 Aug 20243.33%6.09
13 Sep 20242.84%5.60
30 Sep 20242.63%1.66
15 Oct 20244.08%5.58
31 Oct 20243.76%6.85
15 Nov 20242.63%1.1310-Q filed, results (8-K)
29 Nov 20242.67%2.74
13 Dec 20243.61%2.82
31 Dec 20244.58%2.06

See also: RIGEL PHARMACEUTICALS INC's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.